Qingxin Kaiqiao Fang decreases Tau hyperphosphorylation in Alzheimer's disease via the PI3K/Akt/GSK3β pathway in vitro and in vivo

被引:7
|
作者
Liu, Shuo [1 ,2 ,3 ]
Xu, Luting [1 ,2 ,3 ]
Shen, Yan [1 ,2 ,3 ]
Wang, Liuying [1 ,2 ,3 ]
Lai, Xiaoxiao [1 ,2 ,3 ]
Hu, Haiyan [1 ,2 ,3 ]
机构
[1] Wenzhou Med Univ, Affiliated Hosp 2, 109 Xue Yuan Xi Rd, Wenzhou 325000, Peoples R China
[2] Wenzhou Med Univ, Yuying Childrens Hosp, 109 Xue Yuan Xi Rd, Wenzhou 325000, Peoples R China
[3] Wenzhou Med Univ, Clin Coll 2, Wenzhou 325003, Peoples R China
基金
中国国家自然科学基金;
关键词
Alzheimer's disease; Qingxin Kaiqiao Fang; Traditional Chinese medicine; Tau APP/PS1; PI3K/Akt/GSK3 beta pathway; INDUCED APOPTOSIS; PC12; CELLS; BETA; INSULIN; INHIBITION; MECHANISMS; PATHOLOGY;
D O I
10.1016/j.jep.2023.117031
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Alzheimer's disease (AD) belongs to the category of "senile dementia" in traditional Chinese medicine. AD is associated with brain emptiness or collaterals blocked by phlegm-heat. "Fumanjian" from Jingyue Quanshu treats dementia by promoting qi circulation, alleviating depression, eliminating turbidity, cultivating positivity, and dispelling evil spirits. Qingxin Kaiqiao Fang (QKF), derived from Fumanjian, is effective in treating AD owing to previously mentioned clinical effects. Elucidating the mechanism (s) of action of QKF on AD associated with phlegm-heat may be beneficial for therapeutic management; however, further research is needed. Aim of the study: This study aimed to determine the role of the PI3K/Akt pathway in AD, especially the specific effector protein involved, and explore the efficacy of QKF in treating AD by modulating the PI3K/Akt signal. Materials and methods: High-performance liquid chromatography-Q-orbitrap-mass spectrometry was used to analyze the chemical components of QKF. Subsequently, APP/PS1 double-transgenic mice were used for behavioral tests, and hematoxylin-eosin and Nissl staining were used to assess the neuroprotective and cognitive effects of QKF. Cerebrospinal fluid pharmacology was used in in vitro validation, and A beta 25- 35 was used to induce PC12 cells to establish the AD cell model. Various methods, including immunohistochemistry, Western blotting, quantitative real-time polymerase chain reaction, morphological assay, cell counting kit-8(CCK-8) assay, and terminal deoxynucleotide transferase (TdT)-mediated dUTP nick-end labeling (TUNEL)staining, were used to evaluate the effect of QKF on Tau hyperphosphorylation and anti-apoptosis. These methods also assessed the influence of QKF on the PI3K/Akt/GSK3 beta pathway involving the mRNA and protein expressions. Finally, the inhibitor - LY294002 was used for reverse validation. Results: We identified 295 chemical components in the water extract of QKF.QKF improved spatial cognition and learning memory in APP/PS1 mice, protected PC12 cell morphology, improved cell survival, reduced A beta 25-35induced apoptosis, and inhibited the hyperphosphorylation of Tau protein via the PI3k/Akt/GSK3 beta signaling pathway. Furthermore, this protective effect of QKF was reduced by LY294002 in vitro. Conclusions: QKF can improve spatial cognition, learning, and memory abilities in APP/PS1 mice and protect PC12 cells. Decreasing the Tau hyperphosphorylation in AD exhibits curative efficacy on AD via the PI3K/Akt/ GSK3 beta pathway in vitro and in vivo.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Dendrobium nobile Lindl. alkaloid decreases Tau hyperphosphorylation via regulating PI3K/Akt/GSK-3β pathway in vitro and in vivo
    Huang, Juan
    Huang, Nanqu
    Qiu, Yu
    Shi, Jingshan
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2024, 322
  • [2] The PI3K/AKT/GSK3β pathway is not involved in early Alzheimer's disease
    Lim, J.
    Engel, M.
    Witting, P.
    Ooi, L.
    Sutherland, G.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 325 - 325
  • [3] Berberine Alleviates Tau Hyperphosphorylation and Axonopathy-Associated with Diabetic Encephalopathy via Restoring PI3K/Akt/GSK3β Pathway
    Wang, Shanshan
    He, Benhong
    Hang, Weijian
    Wu, Ninghua
    Xia, Liangtao
    Wang, Xu
    Zhang, Qianying
    Zhou, Xinwen
    Feng, Zuohua
    Chen, Qingjie
    Chen, Juan
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2018, 65 (04) : 1385 - 1400
  • [4] TREM2 Inhibits Tau Hyperphosphorylation and Neuronal Apoptosis via the PI3K/Akt/GSK-3β Signaling Pathway In vivo and In vitro
    Peng, Xiaoqian
    Guo, Hongsong
    Zhang, Xiao
    Yang, Zikang
    Ruganzu, John Bosco
    Yang, Zhuoyuan
    Wu, Xiangyuan
    Bi, Wei
    Ji, Shengfeng
    Yang, Weina
    [J]. MOLECULAR NEUROBIOLOGY, 2023, 60 (05) : 2470 - 2485
  • [5] TREM2 Inhibits Tau Hyperphosphorylation and Neuronal Apoptosis via the PI3K/Akt/GSK-3β Signaling Pathway In vivo and In vitro
    Xiaoqian Peng
    Hongsong Guo
    Xiao Zhang
    Zikang Yang
    John Bosco Ruganzu
    Zhuoyuan Yang
    Xiangyuan Wu
    Wei Bi
    Shengfeng Ji
    Weina Yang
    [J]. Molecular Neurobiology, 2023, 60 : 2470 - 2485
  • [6] Dietary regulation of PI3K/AKT/GSK-3β pathway in Alzheimer’s disease
    Yasuko Kitagishi
    Atsuko Nakanishi
    Yasunori Ogura
    Satoru Matsuda
    [J]. Alzheimer's Research & Therapy, 6
  • [7] Dietary regulation of PI3K/AKT/GSK-3β pathway in Alzheimer's disease
    Kitagishi, Yasuko
    Nakanishi, Atsuko
    Ogura, Yasunori
    Matsuda, Satoru
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2014, 6 (03):
  • [8] Roles of PI3K/AKT/GSK3 Pathway Involved in Psychiatric Illnesses
    Matsuda, Satoru
    Ikeda, Yuka
    Murakami, Mutsumi
    Nakagawa, Yukie
    Tsuji, Ai
    Kitagishi, Yasuko
    [J]. DISEASES, 2019, 7 (01)
  • [9] Sulforaphene Ameliorates Neuroinflammation and Hyperphosphorylated Tau Protein via Regulating the PI3K/Akt/GSK-3β Pathway in Experimental Models of Alzheimer's Disease
    Yang, Wen
    Liu, Yue
    Xu, Qing-Qing
    Xian, Yan-Fang
    Lin, Zhi-Xiu
    [J]. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2020, 2020
  • [10] RETRACTION: Osthole decreases tau protein phosphorylation via PI3K/AKT/GSK-3β signaling pathway in Alzheimer's disease (Retraction of Vol 217, Pg 16, 2019)
    Yao, Yingjia
    Wang, Yameng
    Kong, Liang
    Chen, Yuqing
    Yang, Jingxian
    [J]. LIFE SCIENCES, 2023, 318